ArticleIJID regions2025
Clinical characteristics and prognostic outcomes of pediatric tuberculosis in a tertiary care center in China: a 10-year retrospective cohort.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aims to investigate the clinical features and prognostic outcomes of pediatric tuberculosis (TB) in Shenzhen. Methods: This retrospective study collected demographic, clinical, laboratory, and prognostic data from pediatric patients diagnosed with TB between January 2013 and January 2023. Multivariable regression identified risk factors for loss to follow-up and mortality. Results: A total of 358 children were included, and distinct age-related patterns were observed. Younger children had more extrapulmonary TB, whereas older children were more likely to develop pulmonary cavities. Nearly half (47.6%) of the children aged 0-1 years were household contacts of patients with TB, but none of the children had received TB preventive treatment before disease onset. Infants showed the highest rates of drug-induced liver injury (31%) and mortality (13.3%). Microbiological diagnosis was associated with reduced risk of loss to follow-up before treatment completion (hazard ratio 0.463, 95% confidence interval 0.248-0.863, Conclusions: Pediatric TB presents with diverse clinical features across age groups. Early microbiological diagnosis and attention to high-risk populations, especially infants and those with TB meningitis, are essential for improving treatment outcomes. TB preventive treatment in exposed children remains critically underused.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.